Valuation: Proteome Sciences plc

Market Cap 4.91M 6.56M 5.71M 5.4M 9.17M 628M 9.22M 64.37M 24.89M 319M 24.63M 24.08M 1.02B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.9M 26.57M 23.14M 21.9M 37.17M 2.54B 37.36M 261M 101M 1.29B 99.81M 97.59M 4.14B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day-3.45%
Current month-9.68%
1 month-22.01%
3 months-12.50%
6 months-18.84%
Current year-44.00%
1 week 1.11
Extreme 1.11
1.7
1 month 1.11
Extreme 1.11
1.99
Current year 1.11
Extreme 1.11
4.4
1 year 1.11
Extreme 1.11
4.4
3 years 1.11
Extreme 1.11
7.5
5 years 1.11
Extreme 1.11
8.79
10 years 1.11
Extreme 1.11
12.5
Manager TitleAgeSince
Corporate Officer/Principal - 2017-03-31
Corporate Secretary - 2017-07-31
Director TitleAgeSince
Chairman 73 2014-06-29
Director/Board Member 62 2009-12-31
Director/Board Member 71 2014-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/6/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-3.45%0.00%-59.54%-78.12% 6.84M
-0.13%-1.09%-23.81%+0.48% 177B
+0.18%+1.26%-1.91%+13.45% 118B
-2.85%-3.60%+7.03%+73.54% 60.78B
-0.26%+2.81%-3.30%-31.23% 49.53B
-0.75%-0.90%+6.69%+39.70% 48.29B
+0.68%+4.05%+15.03%-8.74% 32.96B
-2.64%-0.83% - - 28.94B
+1.27%+6.49%+42.85%-7.00% 25.48B
+1.13%+5.26%+10.51%-22.76% 21.77B
Average -0.68%+1.18%-0.72%-2.30% 56.33B
Weighted average by Cap. -0.39%+0.21%-3.82%+10.40%

Financials

2024 2025
Net sales 4.89M 6.52M 5.68M 5.38M 9.13M 625M 9.17M 64.07M 24.77M 318M 24.51M 23.97M 1.02B 3.76M 5.01M 4.37M 4.13M 7.02M 480M 7.05M 49.24M 19.04M 244M 18.84M 18.42M 781M
Net income -3.41M -4.55M -3.96M -3.75M -6.36M -436M -6.39M -44.65M -17.27M -221M -17.08M -16.7M -709M -3.06M -4.09M -3.56M -3.37M -5.72M -391M -5.75M -40.13M -15.52M -199M -15.35M -15.01M -637M
Net Debt 13.39M 17.88M 15.58M 14.74M 25.02M 1.71B 25.15M 176M 67.9M 870M 67.18M 65.69M 2.79B 14.99M 20.01M 17.43M 16.5M 28M 1.92B 28.14M 196M 75.98M 974M 75.18M 73.51M 3.12B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
26-09-17 GBX 1.400 -3.45% 726,156
26-09-16 GBX 1.450 0.00% 634,541
26-09-15 GBX 1.450 +3.57% 869,738
26-09-14 GBX 1.400 0.00% 28,411
26-09-11 GBX 1.400 0.00% 33,588
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!